Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cat Health Company is a biotechnology startup focused on developing longevity therapeutics specifically for companion cats. Founded by Oxford-trained scientists, the company applies cutting-edge longevity science and molecular medicine to extend the healthy lifespan of felines. Their research targets cellular senescence and age-related diseases common in geriatric cats. The company is currently conducting clinical trials and aims for regulatory submissions by early 2026. By bridging the gap between human longevity research and veterinary medicine, they seek to provide first-in-class treatments for feline healthspan extension.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gully Cat.